Trial Profile
A Continuous Treatment Study of JNS019 (Topiramate) in Migraine Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Jun 2013
Price :
$35
*
At a glance
- Drugs Topiramate (Primary)
- Indications Migraine
- Focus Adverse reactions
- 04 Mar 2013 New trial record